Cargando…
Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067793/ http://dx.doi.org/10.4103/2230-8210.342224 |
_version_ | 1784700085674704896 |
---|---|
author | Mudalagiri, Manasa Ayyar, Vageesh Bantwal, Ganapathi George, Belinda Appaiah, Sonali |
author_facet | Mudalagiri, Manasa Ayyar, Vageesh Bantwal, Ganapathi George, Belinda Appaiah, Sonali |
author_sort | Mudalagiri, Manasa |
collection | PubMed |
description | Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score retrospectively and determine its usefulness in the management of our PA patients. Results: Sixteen patients were included in the study (56.3% males) with mean age of 34.25 years. Presenting feature was headache in 87.5%, visual disturbance in 50%, seizures in 18.8% and focal deficit in 6.3%. The precipitating event was found in 3 (18.9%). The mean PAS in conservatively managed patients was 0.27 and in those surgically managed was 3.2. Emergent pituitary surgery was performed in 5 patients (31.3%) of which 4 had PAS of >3. Conclusion: Clinical severity based on PAS ≥ 3 appeared to influence the management towards emergency surgical intervention and can be a useful tool to monitor conservatively managed patients and intervene. |
format | Online Article Text |
id | pubmed-9067793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-90677932022-05-05 Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience Mudalagiri, Manasa Ayyar, Vageesh Bantwal, Ganapathi George, Belinda Appaiah, Sonali Indian J Endocrinol Metab Abstracts … Esicon 2021 Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score retrospectively and determine its usefulness in the management of our PA patients. Results: Sixteen patients were included in the study (56.3% males) with mean age of 34.25 years. Presenting feature was headache in 87.5%, visual disturbance in 50%, seizures in 18.8% and focal deficit in 6.3%. The precipitating event was found in 3 (18.9%). The mean PAS in conservatively managed patients was 0.27 and in those surgically managed was 3.2. Emergent pituitary surgery was performed in 5 patients (31.3%) of which 4 had PAS of >3. Conclusion: Clinical severity based on PAS ≥ 3 appeared to influence the management towards emergency surgical intervention and can be a useful tool to monitor conservatively managed patients and intervene. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067793/ http://dx.doi.org/10.4103/2230-8210.342224 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Abstracts … Esicon 2021 Mudalagiri, Manasa Ayyar, Vageesh Bantwal, Ganapathi George, Belinda Appaiah, Sonali Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience |
title | Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience |
title_full | Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience |
title_fullStr | Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience |
title_full_unstemmed | Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience |
title_short | Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience |
title_sort | abstract 103: the pituitary apoplexy score (pas) in the evaluation and management of pituitary apoplexy: a single centre experience |
topic | Abstracts … Esicon 2021 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067793/ http://dx.doi.org/10.4103/2230-8210.342224 |
work_keys_str_mv | AT mudalagirimanasa abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience AT ayyarvageesh abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience AT bantwalganapathi abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience AT georgebelinda abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience AT appaiahsonali abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience |